|
Volumn 17, Issue 6, 1995, Pages 1118-1125
|
Effect of prostaglandin E1 on hepatic function after hepatectomy in patients with chronic liver disease
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ANTITHROMBOCYTIC AGENT;
BILIRUBIN;
CHOLINESTERASE;
PROSTAGLANDIN E1;
ARTICLE;
BLOOD;
CHRONIC DISEASE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFECT;
HUMAN;
JAPAN;
LIVER;
LIVER CELL CARCINOMA;
LIVER DISEASE;
LIVER RESECTION;
LIVER TUMOR;
MIDDLE AGED;
RANDOMIZED CONTROLLED TRIAL;
ADULT;
AGED;
CHRONIC LIVER DISEASE;
CLINICAL ARTICLE;
INTRAVENOUS DRUG ADMINISTRATION;
LIVER CANCER;
LIVER FUNCTION;
LIVER FUNCTION TEST;
PARTIAL HEPATECTOMY;
POSTOPERATIVE PERIOD;
ALANINE TRANSAMINASE;
ALPROSTADIL;
BILIRUBIN;
CARCINOMA, HEPATOCELLULAR;
CHOLINESTERASES;
CHRONIC DISEASE;
HEPATECTOMY;
HUMANS;
JAPAN;
LIVER;
LIVER DISEASES;
LIVER NEOPLASMS;
MIDDLE AGED;
PLATELET AGGREGATION INHIBITORS;
|
EID: 0029415195
PISSN: 01492918
EISSN: None
Source Type: Journal
DOI: 10.1016/0149-2918(95)80090-5 Document Type: Article |
Times cited : (8)
|
References (18)
|